Physician profile
Joselito C Cabaccan
NPI 1801813720
$1,422,624.96
in general payments reported to CMS, 2019-2025
79 companies · $180K in 2025
The $180K reported for 2025 was more than what 99% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $339K · 2020: $197K · 2021: $209K · 2022: $262K · 2023: $126K · 2024: $109K · 2025: $180K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $321K · Travel and Lodging: $50K · Food and Beverage: $27K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Consulting Fee: $7,189 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $321,176.62 |
| Travel and Lodging | $49,981.63 |
| Food and Beverage | $26,546.59 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,341.00 |
| Consulting Fee | $7,189.33 |
| Education | $192.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $566,133.60 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| Novo Nordisk INC | $314,100.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $161,011.70 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $63,192.13 | 2019-2024 | Saphnelo, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58,388.60 | 2019-2025 | Jardiance, Tradjenta, Ofev |
| Sanofi-Aventis U.S. LLC | $52,787.22 | 2019-2025 | |
| Corcept Therapeutics | $40,252.22 | 2019-2024 | Korlym |
| Amgen INC. | $33,635.81 | 2019-2025 | Uplizna, Tepezza, Repatha |
| Mannkind Corporation | $28,017.19 | 2019-2025 | Afrezza |
| Ascendis Pharma Endocrinology INC | $23,932.01 | 2023-2025 | Yorvipath |
| Dexcom, INC. | $19,379.10 | 2019-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $15,666.82 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $15,218.06 | 2019-2020 | |
| Genzyme Corporation | $7,043.23 | 2020-2025 | |
| Ibsa Pharma INC. | $5,565.16 | 2019-2025 | Tirosint, Tirosint, Licart |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $3,106.41 | 2019-2024 | Evkeeza |
| Horizon Therapeutics Plc | $2,088.44 | 2020-2023 | Tepezza |
| Xeris Pharmaceuticals, INC. | $1,999.33 | 2020-2025 | Recorlev, Gvoke Hypopen, Keveyis |
| Radius Health, INC. | $1,178.20 | 2019-2025 | Tymlos |
| Abbvie INC. | $995.86 | 2019-2025 | |
| Amarin Pharma, INC. | $920.86 | 2019-2021 | |
| Abbott Laboratories | $889.44 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $656.67 | 2022-2025 | Benlysta |
| Tandem Diabetes Care, INC. | $567.46 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Pfizer INC. | $562.57 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $555.12 | 2019-2025 | Strensiq |
| Kowa Pharmaceuticals America, INC. | $373.67 | 2020-2021 | |
| Recordati_rare_diseases_inc. | $357.65 | 2021-2025 | Isturisa, Signifor Lar |
| Ascensia Diabetes Care US INC. | $356.15 | 2023-2025 | |
| Madrigal Pharmaceuticals | $338.45 | 2024-2025 | Rezdiffra, Resmetirom |
| Aurinia Pharma U.S., INC. | $307.74 | 2021-2025 | Lupkynis |
| Beta Bionics, INC. | $228.47 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Esperion Therapeutics, INC. | $203.29 | 2020-2025 | Nexletol |
| Zealand Pharma US, INC. | $173.14 | 2021 | |
| Almatica Pharma LLC | $145.85 | 2024-2025 | Teriparatide |
| Shire North American Group INC | $143.14 | 2019 | |
| Antares Pharma, INC. | $138.38 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Ultragenyx Pharmaceutical INC. | $132.90 | 2020-2023 | |
| Verity Pharmaceuticals INC. | $124.92 | 2024-2025 | Tlando |
| Novartis Pharmaceuticals Corporation | $119.95 | 2021-2025 | |
| Sequel Med Tech, LLC | $119.44 | 2025 | Twiist |
| Arbor Pharmaceuticals, INC. | $113.12 | 2019-2021 | |
| Embecta Corp. | $109.02 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Senseonics, Incorporated | $101.00 | 2019-2020 | |
| Eisai INC. | $94.01 | 2019-2024 | |
| Kyowa Kirin, INC. | $90.65 | 2023-2025 | Crysvita |
| Sanofi Pasteur INC. | $72.44 | 2019-2025 | |
| Averitas Pharma INC. | $68.39 | 2023-2024 | Qutenza |
| Insulet Corporation | $66.61 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $65.27 | 2025 | |
| Janssen Biotech, INC. | $48.02 | 2020 | |
| Boston Scientific Corporation | $47.98 | 2019-2020 | |
| Chiesi USA, INC. | $45.40 | 2025 | Mycapssa |
| Sun Pharmaceutical Industries INC. | $40.21 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $39.17 | 2022 | |
| Medtronic Minimed, INC. | $38.68 | 2020 | |
| Organon LLC | $32.47 | 2025 | |
| Ascend Therapeutics US, LLC | $31.85 | 2021 | |
| Medtronic, INC. | $30.53 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $30.40 | 2022 | |
| Strongbridge US INC. | $30.37 | 2020 | |
| Amryt Pharma Holdings Ltd | $30.14 | 2022 | |
| Azurity Pharmaceuticals, INC. | $26.76 | 2024 | Horizant |
| Cequr Corporation | $25.59 | 2023 | Cequr Simplicity |
| Ucb, INC. | $25.00 | 2025 | Bimzelx |
| Tempus Ai, INC | $24.30 | 2025 | Xt Cdx |
| Ionis Pharmaceuticals, INC. | $22.18 | 2025 | Tryngolza |
| Aytu Biopharma, INC. | $20.00 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $19.42 | 2023 | Arcalyst |
| Bigfoot Biomedical INC | $18.02 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $17.55 | 2025 | Imcivree |
| Exact Sciences Corporation | $17.29 | 2024 | Cologuard Collection Kit |
| Seqirus USA INC | $16.75 | 2025 | Flucelvax, Fluad |
| Becton, Dickinson and Company | $15.72 | 2020 | |
| Ani Pharmaceuticals, INC. | $15.69 | 2025 | Purified Cortrophin Gel |
| Halozyme INC | $14.24 | 2023 | |
| Lifescan, INC. | $13.82 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$52,092.75 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joselito Cabaccan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.